← Back to Analyst Consensus 
KYMR Buy
Kymera Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 29
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 1 reiterations from 2 firms
Next Earnings
Oct 29, 2026 (3 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 9, 2026 | Raymond James | initiate | — → Outperform | — | 54% |
| Oct 5, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Sep 22, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Sep 14, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| Sep 10, 2026 | Wolfe Research | upgrade | Peer Perform → Outperform | — | 53% |
| Aug 31, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Aug 27, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Aug 6, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jul 30, 2026 | Deutsche Bank | initiate | — → Hold | — | 57% |
| Jul 28, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Jul 16, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Jul 13, 2026 | RBC Capital | downgrade | Outperform → Sector Perform | — | 55% |
| Jun 30, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| Jun 29, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Jun 29, 2026 | B. Riley Securities | maintain | Buy → Buy | — | 55% |
| Jun 26, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jun 25, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| May 6, 2026 | Canaccord Genuity | initiate | — → Buy | — | 48% |
| Mar 3, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Mar 2, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Mar 2, 2026 | Stephens & Co. | maintain | Overweight → Overweight | — | 54% |
| Feb 26, 2026 | BTIG | maintain | Buy → Buy | $134 | 52% |
| Feb 26, 2026 | Piper Sandler | maintain | Overweight → Overweight | $140 | 54% |
| Feb 3, 2026 | BTIG | reiterate | Buy → Buy | $138 | 52% |
| Jan 28, 2026 | Barclays | maintain | Overweight → Overweight | $133 | 53% |
| Jan 15, 2026 | BTIG | reiterate | Buy → Buy | $138 | 52% |
| Jan 6, 2026 | Wolfe Research | downgrade | Outperform → Peer Perform | $0 | 53% |
| Dec 22, 2025 | B. Riley Securities | maintain | Buy → Buy | $117 | 55% |
| Dec 16, 2025 | RBC Capital | maintain | Outperform → Outperform | $103 | 55% |
| Dec 11, 2025 | Stephens & Co. | maintain | Overweight → Overweight | $110 | 54% |
| Dec 11, 2025 | Mizuho | maintain | Outperform → Outperform | $120 | 52% |
| Dec 10, 2025 | JP Morgan | maintain | Overweight → Overweight | $125 | 54% |
| Dec 9, 2025 | Jefferies | maintain | Buy → Buy | $122 | 52% |
| Dec 9, 2025 | Citigroup | maintain | Buy → Buy | $110 | 54% |
| Dec 9, 2025 | Wells Fargo | maintain | Overweight → Overweight | $116 | 54% |
| Dec 9, 2025 | Truist Securities | maintain | Buy → Buy | $116 | 54% |
| Dec 9, 2025 | Oppenheimer | maintain | Outperform → Outperform | $120 | 52% |
| Dec 9, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $127 | 54% |
| Dec 9, 2025 | Barclays | maintain | Overweight → Overweight | $119 | 53% |
| Dec 9, 2025 | Piper Sandler | reiterate | Overweight → Overweight | $125 | 54% |
| Dec 9, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $134 | 44% |
| Dec 9, 2025 | Leerink Partners | maintain | Outperform → Outperform | $118 | 51% |
| Dec 9, 2025 | B of A Securities | maintain | Buy → Buy | $112 | 53% |
| Dec 9, 2025 | BTIG | maintain | Buy → Buy | $138 | 52% |
| Nov 26, 2025 | Truist Securities | maintain | Buy → Buy | $80 | 54% |
| Nov 5, 2025 | Barclays | maintain | Overweight → Overweight | $70 | 53% |
| Nov 5, 2025 | Wells Fargo | maintain | Overweight → Overweight | $69 | 54% |
| Nov 5, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $84 | 44% |
| Oct 22, 2025 | BTIG | maintain | Buy → Buy | $75 | 52% |
| Oct 21, 2025 | Mizuho | initiate | — → Outperform | $81 | 52% |
Price Target Trend
Jul 9, 2026 Latest: $139.35 Oct 25, 2026
EPS Estimates
0y $-3.85
Lo: $-4.29 Hi: $-3.13
21 analysts ▲3
+1y $-5.10
Lo: $-7.55 Hi: $-3.26
21 analysts ▲1
0q $-1.27
Lo: $-1.47 Hi: $-1.04
21 analysts ▲2
+1q $-1.25
Lo: $-1.52 Hi: $-0.69
21 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days